菌素治疗药物的监管:发展,挑战和机遇
Miriam Fuerst-Wilmes1, Vanessa Respondek1, Michael Schramm1
1Federal Institute for Drugs and Medical Devices, Bonn, Germany.
Frontiers in cellular and infection microbiology
|November 14, 2025
概括
菌体治疗面临监管障碍,但正在取得进展. 新的欧洲指导方针和立法旨在简化对这些针对多药耐药细菌的治疗方法的批准,临床试验是下一个关键步骤.
科学领域:
- 微生物学 微生物学
- 药理学 药理学是指药理学的学科.
- 监管科学 监管科学
背景情况:
- 菌体 (菌体) 对抗多药耐药细菌提供了一种独特的治疗方法.
- 现有的欧洲制药法规并没有完全适应菌体治疗的特定需求.
- 抗生素耐药性的增加需要新的治疗策略,推动了菌体治疗的发展.
研究的目的:
- 审查目前欧洲细菌治疗药物的监管格局.
- 突出最近在协调质量标准和立法框架方面取得的进展.
- 确定菌体治疗批准的关键挑战和未来方向.
主要方法:
- 对欧洲药品批准指南的分析.
- 审查最近的立法变化,包括德国医学研究法.
- 检查已公布的临床使用数据和菌体治疗药物的随机对照试验.
主要成果:
- 菌体治疗产品的协调质量标准于2024年在欧洲药典中实施.
- 欧洲新制药立法和国家法律正在为菌体治疗创造特定途径.
- 尽管取得了进展,但随机对照试验中有效性和安全性的强有力的证明仍在等待.
结论:
- 监管框架正在不断发展,以适应菌体治疗方法.
- 菌体治疗药物的成功批准取决于通过严格的试验证明临床疗效和安全性.
- 持续的研究和监管适应对于实现菌体治疗的潜力至关重要.
相关概念视频
Lytic Cycle of Bacteriophages
77.3K
Bacteriophages, also known as phages, are specialized viruses that infect bacteria. A key characteristic of phages is their distinctive “head-tail” morphology. A phage begins the infection process (i.e., lytic cycle) by attaching to the outside of a bacterial cell. Attachment is accomplished via proteins in the phage tail that bind to specific receptor proteins on the outer surface of the bacterium. The tail injects the phage’s DNA genome into the bacterial cytoplasm. In the...
77.3K
Microorganisms in Medicine and Therapeutics
922
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
922
Drug Regulation
2.7K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
2.7K
Drug Control Governance: Regulatory Bodies and Their Impact
473
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
473
Pharmacovigilance
1.6K
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
1.6K
Gene Regulation in Microbial Communities: Quorum Sensing
486
Quorum sensing is a mechanism of bacterial communication that enables coordinated gene expression in response to changes in population density. This facilitates collective behaviors that enhance survival, resource acquisition, and ecological adaptation. This process relies on small signaling molecules called autoinducers that accumulate as bacterial populations grow. When a critical threshold concentration of autoinducers is reached, bacterial cells collectively modify gene expression,...
486


